Education
About Us
Working with TipRanks
Follow Us
National Research Corp (NRC)
NASDAQ:NRC
NRC Stock Chart & Stats
Day’s Range― - ―
52-Week Range$9.76 - $26.02
Previous CloseN/A
Volume18.02K
Average Volume (3M)91.03K
Market Cap
$284.82M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)16.3
Beta0.54
Next Earnings
Oct 27, 2025EPS EstimateN/A
Next Dividend Ex-Date
Sep 26, 2025Dividend Yield3.84%
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding22,785,421
10 Day Avg. Volume87,629
30 Day Avg. Volume91,027
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$17.00Price Target Upside36.00% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering0
National Research News
NRC FAQ
What was National Research Corp’s price range in the past 12 months?
National Research Corp lowest stock price was $9.76 and its highest was $26.02 in the past 12 months.
What is National Research Corp’s market cap?
National Research Corp’s market cap is $284.82M.
When is National Research Corp’s upcoming earnings report date?
National Research Corp’s upcoming earnings report date is Oct 27, 2025 which is in 86 days.
How were National Research Corp’s earnings last quarter?
National Research Corp released its earnings results on Jul 28, 2025. The company reported -$0.005 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.005.
Is National Research Corp overvalued?
According to Wall Street analysts National Research Corp’s price is currently Undervalued.
Does National Research Corp pay dividends?
National Research Corp pays a Quarterly dividend of $0.12 which represents an annual dividend yield of 3.84%. See more information on National Research Corp dividends here
What is National Research Corp’s EPS estimate?
National Research Corp’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does National Research Corp have?
National Research Corp has 22,785,421 shares outstanding.
What happened to National Research Corp’s price movement after its last earnings report?
National Research Corp reported an EPS of -$0.005 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -4.878%.
Which hedge fund is a major shareholder of National Research Corp?
Currently, no hedge funds are holding shares in NRC
National Research Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$17.00 (36.00% Upside)
$17.00 (36.00% Upside)
Hedge Fund Trend
Decreased
By 1.8K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $34.0K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-49.56%
12-Months-Change
Fundamentals
Return on Equity
58.28%
Trailing 12-Months
Asset Growth
18.71%
Trailing 12-Months
Company Description
National Research Corp
National Research Corporation (NRC) is a leading provider of analytics and insights for the healthcare industry. The company specializes in healthcare intelligence and patient experience solutions, offering a suite of services designed to measure and enhance patient satisfaction, engagement, and loyalty. Through its comprehensive data-driven solutions, NRC helps healthcare providers understand and improve their performance and patient outcomes.
NRC Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call highlighted the company's strategic plans to expand its market and integrate innovative AI solutions, with positive organizational changes and financial management. However, financial results were flat year-over-year, and there is an expectation of increased net debt due to ongoing investments.Read More>Technical Analysis
Ownership Overview
41.71% Insiders
17.55% Mutual Funds
0.07% Other Institutional Investors
32.06% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---